Cancer places a substantial burden on European societies. It accounts for 23% of all deaths and around 17% of disability-adjusted life years (DALYs), making it one of the most significant causes of the overall disease burden. Against this backdrop, cancer is often thought of as a growing financial threat to health systems. Yet the Comparator Report on Cancer in Europe 2025 by the Swedish Institute for Health Economics (IHE) commissioned by the EFPIA Oncology Platform tells a more nuanced and more encouraging story.

Europe is achieving better cancer outcomes without cancer overwhelming health budgets. In fact, cancer care is delivering increasing value for money.

Discover the second blog in the serie.

The fast-paced negotiations on the AI omnibus risk becoming a missed opportunity to address the challenges industrial companies, from healthcare and manufacturing to energy and automotive, face when implementing the AI Act in practice.

Read the full statement here.